HIV Medicine

The management of dyslipidaemias in antiretroviral-treated HIV infection: a systematic review
pp. 325-334(10)
Authors: McGoldrick, C; Leen, CLS

Interactions between protease inhibitors and acid-reducing agents: a systematic review
pp. 335-345(11)
Authors: Béïque, L; Giguère, P; la Porte, C; Angel, J

Use of metabolic drugs and fish oil in HIV-positive patients with metabolic complications and associations with dyslipidaemia and treatment targets
pp. 346-356(11)
Authors: Normén, L; Yip, B; Montaner, J; Harris, M; Frohlich, J; Bondy, G; Hogg, RS

Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women
pp. 357-366(10)
Authors: Phanuphak, N; Apornpong, T; Teeratakulpisarn, S; Chaithongwongwatthana, S; Taweepolcharoen, C; Mangclaviraj, S; Limpongsanurak, S; Jadwattanakul, T; Eiamapichart, P; Luesomboon, W; Apisarnthanarak, A; Kamudhamas, A; Tangsathapornpong, A; Vitavasiri, C; Singhakowinta, N; Attakornwattana, V; Kriengsinyot, R; Methajittiphun, P; Chunloy, K; Preetiyathorn, W; Aumchantr, T; Toro, P; Abrams, EJ; El-Sadr, W; Phanuphak, P

Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006
pp. 367-373(7)
Authors: Smyth, K; Affandi, JS; McArthur, JC; Bowtell-Harris, C; Mijch, AM; Watson, K; Costello, K; Woolley, IJ; Price, P; Wesselingh, SL; Cherry, CL

The public health impact of widespread availability of nonoccupational postexposure prophylaxis against HIV
pp. 374-381(8)
Authors: Poynten, IM; Smith, DE; Cooper, DA; Kaldor, JM; Grulich, AE

HIV forensics: pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmission
pp. 382-387(6)
Authors: Bernard, EJ; Azad, Y; Vandamme, AM; Weait, M; Geretti, AM

Ferritin levels during structured treatment interruption of highly active antiretroviral therapy
pp. 388-395(8)
Authors: Boom, J; Kösters, E; Duncombe, C; Kerr, S; Hirschel, B; Ruxrungtham, K; de Mast, Q; Kosalaraksa, P; Ulbolyam, S; Jupimai, T; Ananworanich, J

Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification
pp. 396-400(5)
Authors: Amellal, B; Katlama, C; Calvez, V

Race and ethnicity impact on the maximum proliferative response in peripheral blood lymphocytes from HIV-seropositive individuals
pp. 401-405(5)
Authors: Kolber, MA; Saenz, MO; Gómez-Marín, O; Tamariz, LJ

Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy
pp. 406-410(5)
Authors: Patterson, K; Napravnik, S; Eron, J; Keruly, J; Moore, R

Adverse events experienced by three children taking tenofovir and didanosine in combination
pp. 411-411(1)
Authors: Hawkins, S; Ball, C

Aweeka FT, Kang M, Yu J-Y, Lizak P, Aston B, Chung RT. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team. HIV Med 2007; 8: 288-294
pp. 412-412(1)